CANTON, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Avitar, Inc. (OTC Bulletin Board: - ), developer of the world's first rapid, on-site, oral fluid-based screening test for drugs-of-abuse, will be a featured presenter at a national audio technical conference under the auspices of the American Society of Safety Engineers (ASSE), the nation's largest and oldest professional safety organization with more than 30,000 members, on Wednesday, September 20th, from 11:00 AM to 12:30 PM (CT). The conference, entitled Issues and Implications of Drug Abuse & Examining the Need for Drug Testing, will review the current methods of drug testing, their benefits and drawbacks, as well as discuss the operational, legal and economic considerations of an effective drug-free workplace testing program.
"Following our presentation at the ASSE National Conference in Seattle in June, we are again honored to have been chosen to address Safety, Health and Environmental professionals across the United States. The ASSE clearly recognizes that impairment by drug or alcohol use constitutes avoidable workplace hazards and costs," said Peter P. Phildius, Avitar's Chief Executive Officer. "Our advocacy for random drug testing, as a critical element in an effective drug-free workplace program, is being recognized by those most concerned with improving worker safety and health."
"ASSE is excited to host this important call and we have received a lot of initial interest from our members," said Tim Fisher, ASSE Director, Practices and Standards. "We are thrilled that we have this opportunity to host some of the leading experts in the field of drug abuse and we look forward to a very fruitful and enlightening discussion."
Additional information regarding the conference can be found at http://www.asse.org/drugtestingsupport/.
Avitar, Inc. develops, manufactures and markets innovative and proprietary products. Their field includes the oral fluid diagnostic market, the disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Avitar manufactures ORALscreen®, the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse, as well as HYDRASORB®, an absorbent topical dressing for moderate to heavy exudating wounds. Avitar is also developing diagnostic strategies for disease and clinical testing in the estimated $25 billion in-vitro diagnostics market. Conditions targeted include influenza, diabetes, and pregnancy. For more information, see Avitar's website at https://avitarinc.com.
Founded in 1911, the Des Plaines, IL-based ASSE is the largest and oldest professional safety organization and is committed to protecting people, property and the environment. It has more than 30,000 occupational safety, health and environmental professional members who manage, supervise research and consult on safety, health, transportation and environmental issues in all industries, government, labor and education. For more information check ASSE's website at http://www.asse.org.
Safe Harbor Statement
This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements.
Jay C. Leatherman
The Investor Relations Group
Erika Moran / Tom Caden,
Lynn Granito / Susan Morgenbesser,